|
|
174-M.
 | C-Peptide Inhibitors of HIV-1 Entry Do not Disrupt Formation of a 6-Helix Bundle Structure in gp41
N. Kilgore, K. Salzwedel, G. Allaway, and C. Wild*
Panacos Pharmaceuticals Inc., Gaithersburg, MD
|
175-M.
| The Role of Cell Surface Heparan Sulfate Proteoglycans (HSPGs) in HIV-1 Viral Assembly and HIV-1 Tat Cellular Uptake
E. G. Argyris*, M. E. Meyer, K. J. Williams, and R. J. Pomerantz
Jefferson Med. Coll., Thomas Jefferson Univ., Philadelphia, PA
|
176-M.
| Role of the Viral Envelope-Matrix Complex and Host Cytoskeleton in the Selective Incorporation of Host ICAM-1 Protein into HIV-1
Y. Beauséjour* and M. J. Tremblay
Univ. Laval, Ste-Foy, QC, Canada
|
| 177-M. | Incorporation of Host CD80 (B7.1) and CD86 (B7.2) Glycoproteins into HIV-1 Increases Viral Infectivity in Primary Human Mononuclear Cells
S. Bounou*, J. F. Giguère, and M. J. Tremblay
Univ. of Laval, Ste-Foy, QC, Canada
|
| 178-M. | Low Quantity of SU on HIV Is Due to Low Incorporation of Envelope Glycoproteins and not to Shedding
E. Chertova*1, J. Bess1, B. Crise1, R. Sowder II1, T. Schaden1, J. Hilburn1, J. Hoxie2, L. Henderson1, and L. O. Arthur1
1SAIC, Frederick, MD and 2Univ. of Pennsylvania, Philadelphia
|
| 179-M. | Poor Fitness of Subtype C HIV-1 Isolates Is Controlled by the Efficiency of Host Cell Entry and Maps to the Env Gene
E. Arts*, S. Ball, A. Ahabra, and A. Marozsan
Case Western Reserve Univ., Cleveland, OH
|
